Many studies have suggested that the autoantigens triggering production of SSA and SSB autoantibodies, Ro and La, are released locally in exocrine tissue due to early disease triggers (viral infection, ER stress, apoptosis) where they can be processed in TLS to generate autoantibodies (70). Here, TRIM21 is linked to viral infectious disease.